Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-07

Clinical Trial Update: Eggs and Age-related Macular Degeneration (EggsAMD) Study. [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 clinical trial named EggsAMD is currently recruiting participants to investigate treatment for intermediate age-related macular degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Kathryn Starr | Conditions: Intermediate Age-Related Macular Degeneration | EARLY_Phase 1 | Status: RECRUITING